Home
http://www.virbac.fr/ http://www.boehringer-ingelheim.com/ http://www.novartis.com/ http://www.animalhealth.bayerhealthcare.com/
vetcontact
Vetrinär
Tiermedizin
  WELCOME  
vetcontact
Vetrinär
Tiermedizin
  Home  
  Login / Newsletter  
vetcontact
Vetrinär
Tiermedizin
  CONTACTS  
vetcontact
Vetrinär
Tiermedizin
  Classifieds  
  New Products  
  VetCompanies  
  VetSchools  
vetcontact
Vetrinär
Tiermedizin
  PROFESSION  
vetcontact
Vetrinär
Tiermedizin
  Edutainment  
  VetAgenda  
  Presentations  
  Posters  
  ESAVS  
  Specialisation  
vetcontact
Vetrinär
Tiermedizin
  INSIGHT  
vetcontact
Vetrinär
Tiermedizin
  Congress News  
  Picture Galleries  
vetcontact
Vetrinär
Tiermedizin
  PRODUCTS  
vetcontact
Vetrinär
Tiermedizin
  Bayer  
  Boehringer Ing.  
  Novartis  
  Virbac

 
  Simply book for less...  
    

Bovine    Equine    Small Animal Practice    Swine Practice    Articles    Vetjournal    
deutsch english español polski francais
Home / WELCOME / Archiv / Small Animal Practice /     
 
Enalapril versus placebo in canine idiopathic glomerulonephritis
Enalapril is a well-known blocker of the ACE system in dogs and cats. Is it also effective in the therapy of naturally occurring, idiopathic glomerulonephritis in dogs?

Twenty-nine adult dogs were included in a blinded, multicenter, prospective clinical trial with membranous (n = 16) and membranoproliferative (n = 13).

Dogs were randomly assigned to receive either EN (0.5 mg/kg PO q12-24h; n = 16) or placebo (n = 14) for 6 months (1 dog was treated first with the placebo and then with EN). All dogs were treated with low-dose aspirin (0.5-5 mg/kg PO q12-24h) and fed a commercial diet. At baseline, serum creatinine (SrCr), systolic blood pressure (SBP), and glomerular histologic grade were not different between groups, but the urine protein/creatinine ratio (UP/C) was greater in the EN group compared with the placebo group (8.7 +/- 4.4 versus 4.7 +/- 2.3).
After 6 months of treatment, the change in UP/C from baseline was significantly different between groups (EN = -4.2 +/- 1.4 versus 1.9 +/- 0.9 in the placebo group). When data were adjusted for changes in SrCr (SrCr X UP/C) a similar significant reduction was noted ( 2.2 +/- 15.2 versus 8.4 +/- 10.1). The change in SBP after 6 months of treatment also was significantly different between groups (EN = -12.8 +/- 27.3 versus 5.9 +/- 21.5 mm Hg in the placebo group).

Response to treatment was categorized as improvement (assigned a value of 2), no progression (assigned a value of 1), and progression (assigned a value of 0).

Response was significantly better in the EN group (1.4 +/- 0.8) compared with the placebo group (0.3 +/- 0.5).
These results suggest that EN treatment is beneficial in dogs with naturally occurring idiopathic GN.

Source: Grauer GF,et al (2000): Effects of enalapril versus placebo as a treatment for canine idiopathic glomerulonephritis. In: J Vet Intern Med 2000 Sep-Oct;14(5):526-33




Tell a friend   |   Print version   |   Send this article

SMALL ANIMAL PRACTICE

Body Weight, Body Condition, and Muscle Condition in Cats with Hyperthyroidismmembers
Hyperthyroidism is the most common endocrinopathy in cats. Still the contribution of fat loss versus muscle wasting to the loss of body weight seen in hyperthyroid cats is unknown, and so the objective of this study was to investigate body weight, body condition score (BCS), and muscle condition score (MCS) in almost 500 hyperthyroid cats.

  • Prevalence of impinged spinous processes in asymptomatic dogsmembers
  • Intraocular pressure curve protocol for use in dogsmembers
  • Atopic dermatitis and the intestinal microbiota in dogs and menmembers
  • Bacterial contamination and DNA quantification in stored blood units members
  • Atypical chorioretinal coloboma in a Golden Retrievermembers
  • Oral direct factor Xa inhibitor anticoagulant in healthy adult horsesmembers
  • Use of three human cervical fusion implants in the canine cervical vertebral columnmembers
  • Radiotherapy for canine adrenocortical tumours with vascular invasionmembers
  • Intrahepatic portocaval shunt in dogs - diagnosis and therapymembers
  • Renal Abnormalities in Dogs with Coccidioidomycosismembers
  • Novel retinopathy in related Gordon settersmembers
  • Tolerability of a rapid-escalation vinblastine-prednisolone protocol in canine mast cell tumoursmembers


  • [ Home ] [ About ] [ Contact / Request ][ Disclaimer ]

    Copyright © 2001-2016 VetContact GmbH
    All rights reserved